Prestige Consumer Healthcare Inc. Financials

Market Capitalization $3.79 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	18.71
Forward PE	16.09
Price to Sales TTM	$3.41
Price to Book MRQ	$2.19
Enterprise to Revenue	4.32
Enterprise to EBITDA	13.45

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2024-03-31
Most Recent Quarter	2024-09-30
Profit Margin	18.54%
Operating Margin	29.72%
Return on Assets TTM	6.12%
Return on Equity TTM	12.61%

Income Statement

Revenue TTM	$1,110,658,944
Revenue per Share TTM	$22.31
Quarterly Revenue Growth	-0.90%
Gross Profit TTM	$622,113,024
EBITDA	$355,768,000
Net Income to Common TTM	$205,948,992
Diluted EPS TTM	$4.10
Quarterly Earnings Growth YoY	1.50%

Balance Sheet

Total Cash MRQ	$51,540,000
Total Cash per Share MRQ	$1.04
Total Debt MRQ	$
Total Debt to Equity MRQ	61.26
Current Ratio MRQ	3.56
Book Value per Share MRQ	$35.03

Cash Flow

Operating Cash Flow TTM	$262,955,008
Levered Free Cash Flow TTM	$189,474,128

PBH Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	49,405,500
Float Shares	48,728,599
Avg 10 Volume	278,710
Avg 30 Volume	None
Shares Short	2,520,119
Short Ratio	9.80
Short % of Shares	7.40%
% Held by Insiders	1.30%
% Held by Institutions	105.99%

Stock Price Summary

Beta	0.47
Fifty Two Week Low	$60.00
Fifty Two Week High	$86.36
Fifty Two Week Change	17.19%
Day 50 MA	$80.49
Day 200 MA	$72.44

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date	2013-12-27
Last Split Factor
Last Split Date